[CLDX] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
28-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 11.55%
YoY- -17.58%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 1,517 268 967 1,613 407 163 174 323.04%
PBT -38,260 -30,502 -29,361 -26,487 -26,784 -36,004 -23,050 40.14%
Tax -2,979 -3,459 -6,946 -2,796 -912 16,564 -1,486 58.92%
NP -38,260 -30,502 -22,415 -23,691 -26,784 -52,568 -21,564 46.50%
Tax Rate - - - - - - - -
Total Cost 39,777 30,770 23,382 25,304 27,191 52,731 21,738 49.54%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -2,522.08 -11,381.34 -2,317.99 -1,468.75 -6,580.84 -32,250.31 -12,393.10 -65.36%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.81 -0.65 -0.47 -0.50 -0.57 -1.12 -0.46 45.77%
EPS Diluted -0.81 -0.65 -0.47 -0.50 -0.57 -1.12 -0.46 45.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.